Joseph Larosa - Sep 9, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
Sep 9, 2022
Transactions value $
-$7,039,901
Form type
4
Date filed
9/12/2022, 04:30 PM
Previous filing
Apr 11, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $8.11M +30K +259.07% $270.43 41.6K Sep 9, 2022 Direct
transaction REGN Common Stock Tax liability -$15.2M -20.7K -49.86% $730.96 20.9K Sep 9, 2022 Direct
holding REGN Common Stock 2.11K Sep 9, 2022 2021 GRAT
holding REGN Common Stock 5.32K Sep 9, 2022 2022 GRAT
holding REGN Common Stock 335 Sep 9, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30K -75% $0.00 10K Sep 9, 2022 Common Stock 30K $270.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.